Why invest in Hofseth BioCare?
A strong ESG-profile, and patented processes coupled with world class R&D with diversified pipelines including research programs on asthma, COVID-19 and gastro
Ticker:
HBC
Last updated:
18.05.2022 16:25
Latest
3.91 NOK
Change
0.06
Change (%)
1.56
Share information
IR contact
News
Reports
Governance
LATEST REPORT
Quarterly Report Q3
Download our latest report, or view all quarterly and yearly reports in the archives.
NEXT UP
Financial calendar
Half-yearly Report
26.08.2022
Quarterly Report Q1
06.05.2022
Quarterly Report Q3
11.11.2022
Quarterly Report Q4
10.02.2023
Investor presentation
Download our latest investor presentation in PDF-format for a even deeper insight into our current ongoing business and future potential.
Download presentation
Stock exchange notices
View all notices
Contact investor relations
